Pegylated interferon-α, ribavirin, and rituximab combined ...
Peginterferon-α2a/ribavirin
Transcript of Peginterferon-α2a/ribavirin
Reactions 1021 - 2 Oct 2004
Peginterferon-α2a/ribavirin
IgA nephropathy: case reportA 54-year-old man developed IgA nephropathy during
treatment with peginterferon-α-2a and ribavirin for chronichepatitis C infection.
Nine days after starting treatment with SC peginterferon-α-2a 180 µg/week and ribavirin 600mg twice daily, the manpresented with macroscopic haematuria. Urinalysis revealed> 1000 × 106/L RBCs and > 1000 × 106/L WBCs, and a 24 hoururine collection revealed proteinuria of 1.78 g/day. His serumcreatinine level had increased from 0.09 mmol/L at baseline to0.19 mmol/L, his haemoglobin level had decreased from 172to 140 g/L and he had a bilirubin level of 44 mmol/L, a lactatedehydrogenase level of 741 U/L and a haptoglobin level of< 0.06 g/L. A kidney biopsy revealed acute tubular necrosis,glomerular IgA deposition and mild mesangial proliferation,consistent with IgA nephropathy.
Peginterferon-α-2a and ribavirin were discontinued and theman’s symptoms gradually resolved.Gordon A, et al. Combination pegylated interferon and ribavirin therapyprecipitating acute renal failure and exacerbating IgA nephropathy. NephrologyDialysis Transplantation 19: 2155, No. 8, Aug 2004 - Australia 800987447
1
Reactions 2 Oct 2004 No. 10210114-9954/10/1021-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved